Jörg Debatin

German physician

Born 1961-12-18 in Bad Godesberg (Q153260)

Jörg Debatin is …
instance of (P31):
humanQ5

External links are
P227GND ID114940940
P2671Google Knowledge Graph ID/g/1218r9_y
P213ISNI0000000083659003
P244Library of Congress authority IDn97010397
P1006Nationale Thesaurus voor Auteursnamen ID170109135
P1207NUKAT IDn2013199346
P3368Prabook ID486273
P214VIAF ID25319183
P10832WorldCat Entities IDE39PBJcwFFVytcbvKfDKxVdbBP

P27country of citizenshipGermanyQ183
P108employerUniversity of HamburgQ156725
University of Duisburg-EssenQ696757
P734family nameDebatinQ126364946
DebatinQ126364946
DebatinQ126364946
P735given nameJörgQ1715186
JörgQ1715186
P1412languages spoken, written or signedGermanQ188
P1559name in native languageJörg Debatin
P106occupationphysicianQ39631
university teacherQ1622272
radiologistQ18245236
P21sex or gendermaleQ6581097
P937work locationZürichQ72
HamburgQ1055
EssenQ2066

Reverse relations

author (P50)
Q53580437"All-in-one" imaging protocols for the evaluation of potential living liver donors: comparison of magnetic resonance imaging and multidetector computed tomography.
Q48471774A multidisciplinary quality management system for the early treatment of severely injured patients: implementation and results in two trauma centers
Q45130086Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET.
Q35635208Acquisition protocol considerations for combined PET/CT imaging.
Q45305209Assessment of liver tissue after radiofrequency ablation: findings with different imaging procedures.
Q53643805Assessment of normal, inflammatory, and tumor-bearing lymph nodes with contrast-enhanced interstitial magnetic resonance lymphography: preliminary results in rabbits.
Q51726679Assessment of ventricular function with single breath-hold real-time steady-state free precession cine MR imaging.
Q36186346Colonography by magnetic resonance imaging
Q44787044Comparison of PET, CT, and dual-modality PET/CT imaging for monitoring of imatinib (STI571) therapy in patients with gastrointestinal stromal tumors
Q39658070Comprehensive time-resolved MRI of peripheral vascular malformations
Q74512762Contrast-enhanced magnetic resonance imaging (MS-325) in a murine model of systemic lupus erythematosus
Q53472985Contrast-enhanced multidetector-CT cholangiography after living donor liver transplantation.
Q51605962Coronary artery calcium score: influence of reconstruction interval at 16-detector row CT with retrospective electrocardiographic gating.
Q45154922Dark lumen magnetic resonance colonography in a rodent polyp model: initial experience and demonstration of feasibility
Q78532327Detection and characterization of intracardiac thrombi on MR imaging
Q44324872Detection of atherosclerosis: systemic imaging for systemic disease with whole-body three-dimensional MR angiography--initial experience
Q44497567Detection of atherosclerotic plaque with Gadofluorine-enhanced magnetic resonance imaging
Q36264035Detection of pulmonary nodules using a 2D HASTE MR sequence: comparison with MDCT.
Q45076929Dose optimization of mannitol solution for small bowel distension in MRI.
Q44757229Dual-modality PET/CT scanning with negative oral contrast agent to avoid artifacts: introduction and evaluation
Q44662207Effect of oral contrast agents on computed tomography-based positron emission tomography attenuation correction in dual-modality positron emission tomography/computed tomography imaging
Q53573661Elective full-body screening examinations: a plea for MRI.
Q36378667Evaluation of living liver donors with an all-inclusive 3D multi-detector row CT protocol
Q46446467Evaluation of steady state free precession imaging of the pancreas
Q44170634Focal tracer uptake: a potential artifact in contrast-enhanced dual-modality PET/CT scans.
Q40451239Full-body cardiovascular and tumor MRI for early detection of disease: feasibility and initial experience in 298 subjects.
Q35679958Gadopentetate dimeglumine-enhanced three-dimensional MR-angiography: dosing, safety, and efficacy
Q80223089HASTE MRI versus chest radiography in the detection of pulmonary nodules: comparison with MDCT
Q37357103Healthcare costs for new technologies
Q43960938Imaging of myocardial infarction: comparison of magnevist and gadophrin-3 in rabbits
Q35788357Imaging of myocardial perfusion with magnetic resonance
Q80547179Increased time rate of change of gradient fields: effect on peripheral nerve stimulation at clinical MR imaging
Q78478800Inductively coupled stent antennas in MRI
Q78532338Interstitial MR lymphography with MS-325: characterization of normal and tumor-invaded lymph nodes in a rabbit model
Q79074490Interventional MR angiography with a floating table
Q78739710Interventional MRA using actively visualized catheters, TrueFISP, and real-time image fusion
Q44259120Intraindividual comparison of gadopentetate dimeglumine, gadobenate dimeglumine, and gadobutrol for pelvic 3D magnetic resonance angiography
Q44757227Intraoperative radiation therapy in liver tissue in a pig model: monitoring with dual-modality PET/CT.
Q34779595MR angiography for assessment of peripheral vascular disease
Q35083369MR angiography of the chest
Q74631162MR angiography with a new rapid clearance blood pool agent (P792): initial experience in rabbits
Q78478830MR angiography with a new rapid-clearance blood pool agent: Initial experience in rabbits
Q80936844MR angiography with venous compression
Q30684659MR colonography with barium-based fecal tagging: initial clinical experience
Q35985764MR imaging of apparent small-bowel perfusion for diagnosing mesenteric ischemia: feasibility study.
Q34605164MR imaging of the vessel wall
Q78685600MR venography using an intravascular contrast agent: results from a multicenter phase 2 study of dosage
Q39698495MR-based assessment of potential living related liver donors
Q76342693MR-based full-body preventative cardiovascular and tumor imaging: technique and preliminary experience
Q51689572MRI of the liver: can True FISP replace HASTE?
Q35023728Magnetic resonance colonography with fecal tagging: an innovative approach without bowel cleansing
Q74494004Multidetector computed tomographic cholangiography in the evaluation of potential living liver donors
Q44598378Non-small cell lung cancer: dual-modality PET/CT in preoperative staging
Q43972967Optimization of contrast dosage for gadobenate dimeglumine-enhanced high-resolution whole-body 3D magnetic resonance angiography
Q30794310Optimization of oral contrast agents for MR imaging of the small bowel
Q30884633Oral contrast agents for small bowel MRI: comparison of different additives to optimize bowel distension
Q47829449Parallel acquisition techniques for accelerated volumetric interpolated breath-hold examination magnetic resonance imaging of the upper abdomen: assessment of image quality and lesion conspicuity.
Q44780653Peripheral vasculature: whole-body MR angiography with midfemoral venous compression--initial experience
Q35840426Positron emission tomography/computed tomography--imaging protocols, artifacts, and pitfalls
Q53674736Potential living liver donors: evaluation with an all-in-one protocol with multi-detector row CT.
Q34168447Radiation exposure during cardiac CT: effective doses at multi-detector row CT and electron-beam CT.
Q39597433Right-lobe living related liver transplantation: evaluation of a comprehensive magnetic resonance imaging protocol for assessing potential donors
Q35112235Screening with MRI: A new “all inclusive” protocol
Q30992640Small bowel hydro-MR imaging for optimized ileocecal distension in Crohn's disease: should an additional rectal enema filling be performed?
Q40486062The future of hospital-based radiological imaging
Q48539910Three-dimensional volumetric interpolated breath-hold MR imaging for whole-body tumor staging in less than 15 minutes: a feasibility study
Q44409335Time-resolved three-dimensional MR imaging of gastric emptying modified by IV administration of erythromycin
Q35635220To enhance or not to enhance? 18F-FDG and CT contrast agents in dual-modality 18F-FDG PET/CT.
Q81242426Total-body 3D magnetic resonance angiography influences the management of patients with peripheral arterial occlusive disease
Q74133728Ultrasmall superparamagnetic iron oxide-enhanced MR imaging of atherosclerotic plaque in hyperlipidemic rabbits
Q35963508Unknown primary tumors: detection with dual-modality PET/CT--initial experience
Q39648179Using a 1 M Gd‐chelate (gadobutrol) for total‐body three‐dimensional MR angiography: Preliminary experience
Q53555256Variability of preoperatively determined hepatic volumes in potential living liver donors.
Q39697747Venous compression at high-spatial-resolution three-dimensional MR angiography of peripheral arteries
Q39659567View from above
Q32064394Visualization of swallowing using real-time TrueFISP MR fluoroscopy
Q39685398Whole-body 3D MR angiography of patients with peripheral arterial occlusive disease
Q47939703Whole-body MR imaging: evaluation of patients for metastases
Q74506971Whole-body MRI using a rolling table platform for the detection of bone metastases
Q44705082Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology
Q39606975Whole-body three-dimensional MR angiography with a rolling table platform: initial clinical experience
Q74339545[Arterial vascular screening with whole body MR angiography]

Q96336944Health Innovation Hubdirector / managerP1037

The articles in Wikimedia projects and languages

      Jörg Debatinwikipedia

Search more.